CA
NZ
UK
AU
IND
US
PubMatic, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 9, 2026, reporting third-quarter revenue of $79,577 thousand and net income of $5,545 thousand.
Alexander De Bock, Chief Financial Officer of Lucid Group, Inc. (NASDAQ:LCID), filed a Form 4 on November 9, 2026, disclosing the acquisition of 836,036 performance-based restricted stock units on November 5, 2026.
PubMatic, Inc. filed a Form 8-K on November 9, 2026, reporting its financial results for the fiscal quarter ended September 30, 2026, and disclosing a $150 million increase to its share repurchase program authorized by its Board of Directors on the same date.
AI Infrastructure Acquisition Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the Securities and Exchange Commission on November 9, 2026, reporting trust account assets of $143,017,909 and net income of $1,177,030 for the third quarter.
Kochav Defense Acquisition Corp. filed Definitive Additional Materials (DEFA14A) on November 9, 2026, disclosing updated trust account contribution terms ahead of its extraordinary general meeting scheduled for November 13, 2026.
Miluna Acquisition Corp filed its quarterly report on Form 10-Q for the period ended September 30, 2026, with the SEC on November 9, 2026, disclosing financial results and balance sheet data for the blank-check company listed on NASDAQ:MMTX.
W. R. Berkley Corporation and its subsidiary Berkley Insurance Company filed Amendment No. 3 to Schedule 13G on November 9, 2026, disclosing beneficial ownership of Class A ordinary shares in Kochav Defense Acquisition Corp. as of September 30, 2026.
Select Water Solutions, Inc. filed its quarterly report on Form 10-Q with the Securities and Exchange Commission for the period ended September 30, 2026, disclosing share counts and key company details as of November 5, 2026.
Kochav Defense Acquisition Corp. filed a Form 8-K on November 9, 2026, disclosing updated trust account contribution terms ahead of its extraordinary general meeting scheduled for November 13, 2026.
Abeona Therapeutics Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 9, 2026, covering the fiscal quarter ended September 30, 2026.
Please wait processing your request...